Dr. Mika Kontro, MD, PhD, will deliver a presentation titled "Efficacy of Macrophage Checkpoint Clever-1 Inhibition with ...

A revolutionary homeopathic treatment by Dr. A.K. Dwivedi gives renewed hope to patients with rare blood disorders like ITP. The case of 7-year-old Ayushmann Singh, whose platelet count dramatically ...

Geron Corporation (NASDAQ:GERN) is one of the best low priced pharma stocks to buy now. Earlier on May 28, Geron Corporation ...

Regular self-exams and cancer screenings for cancers like skin, colon, cervix, and breast can increase the chances of early ...

A UVA Cancer Center study shows that blood cancer patients who receive partially matched stem cell transplants have survival ...

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for decitabine/cedazuridine plus venetoclax to treat adults with newly diagnosed acute myeloid leukemia ...

Advances in blood stem cell transplants now make it possible for people with blood cancers to get safe and effective ...

Ashwin Kishtagari, MD, of Vanderbilt University Medical Center in Nashville, summarizes 7 studies presented at the EHA 2025 Congress.

The report provides a detailed analysis of the current myelodysplastic syndrome marketed drugs and late-stage pipeline drugs.

The table below is a review of notable updates that occurred in June 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

It took a misplaced elbow, a quirk of Los Angeles geography and some whistling from his wife to produce one of television’s ...